Cerus (CERS) Other Non Operating Income (2010 - 2026)
Cerus (CERS) reported Other Non Operating Income of $150000.0 for Q1 2026, down 75.25% on a YoY basis from $606000.0 in Q1 2025, and up 108.23% sequentially from -$1.8 million in Q4 2025.
Cerus (CERS) Other Non Operating Income (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Other Non Operating Income data on file, last reported at $150000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 75.25% year-over-year to $150000.0; the trailing twelve-month figure through Mar 2026 stood at -$855000.0 (down 2542.86% YoY), and the FY2025 full-year result was $605000.0, up 63.51% from the prior year.
- Other Non Operating Income rose to $150000.0 in Q1 2026, from -$1.8 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.5 million in Q4 2022 to a low of -$1.8 million in Q4 2025.
- A 5-year average of $208705.9 and a median of $165000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 1896.67% in 2023 and slumped 281.19% in 2024, its largest moves.
- Tracing CERS's Other Non Operating Income over 5 years: stood at $2.5 million in 2022, then plunged by 75.96% to $606000.0 in 2023, then tumbled by 281.19% to -$1.1 million in 2024, then sank by 65.94% to -$1.8 million in 2025, then jumped by 108.23% to $150000.0 in 2026.
- Business Quant data shows CERS's Other Non Operating Income at $150000.0 in Q1 2026, -$1.8 million in Q4 2025, and -$28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Cerus | 605.72 Mn | 525.30 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | 845,000.00 |
| Mar 31, 2025 | 606,000.00 |
| Dec 31, 2024 | -1.10 Mn |
| Sep 30, 2024 | 604,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Dec 31, 2023 | 606,000.00 |
| Sep 30, 2023 | 233,000.00 |
| Jun 30, 2023 | 539,000.00 |
| Mar 31, 2023 | 387,000.00 |
| Dec 31, 2022 | 2.52 Mn |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | -30,000.00 |
| Mar 31, 2022 | -198,000.00 |
| Dec 31, 2021 | -1.57 Mn |
| Sep 30, 2021 | 205,000.00 |
| Jun 30, 2021 | 337,000.00 |